Conference Reports

Washington, DC
19 May 2017 - 24 May 2017
Geneva
05 May 2017 - 08 May 2017
Bangkok
12 November 2016 - 15 November 2016
Geneva
13 April 2016 - 16 April 2016
Kuala Lumpur
03 December 2015 - 06 December 2015
14 November 2015 - 15 November 2015
Amsterdam
26 September 2015 - 30 September 2015
Geneva
15 April 2015 - 18 April 2015
Bali
13 November 2014 - 16 November 2014
Munich
06 September 2014 - 10 September 2014
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Audrey Abella, 2 months ago
Fixed-dose combinations of long-acting β2-agonist (LABA) and muscarinic antagonist (LAMA) offered superior efficacy and comparable safety to LAMA or LABA/inhaled corticosteroid (ICS), the two most commonly prescribed first-line treatments for stable moderate-to-very-severe chronic obstructive pulmonary disease (COPD), according to a meta-analysis.
one year ago
At a recent continuing medical education programme, Dr Neil G Snowise, Regional Medical Leader of GlaxoSmithKline Global Respiratory Franchise shed light on the clinical efficacy of Relvar® Ellipta® (fluticasone furoate/vilanterol) for the management of asthma. Highlights of his presentation are summarized below.
one year ago
Afatinib is a potential treatment for metastatic squamous cell carcinoma, a review states.
one year ago
Diabetes mellitus patients have higher risk of developing tuberculosis, especially during the first 12 months following diagnosis, according to a retrospective cohort study.